Variant report

Variant	nsv1043108
Chromosome Location	chr11:47041565-47117248
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:384)
CpG islands
(count:244)
Chromatin interactive
region (count:19)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:384 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:47077706-47078356	K562	blood:	n/a	n/a
2	ARID3A	chr11:47050001-47050005	K562	blood:	n/a	n/a
3	ATF1	chr11:47114615-47114653	K562	blood:	n/a	n/a
4	ATF1	chr11:47056675-47056990	K562	blood:	n/a	n/a
5	ATF1	chr11:47077699-47078228	K562	blood:	n/a	n/a
6	ATF1	chr11:47050378-47050512	K562	blood:	n/a	n/a
7	ATF1	chr11:47109403-47109797	K562	blood:	n/a	n/a
8	ATF1	chr11:47100956-47100982	K562	blood:	n/a	n/a
9	ATF3	chr11:47077776-47078207	K562	blood:	n/a	n/a
10	ATF3	chr11:47100738-47101011	K562	blood:	n/a	n/a
11	BACH1	chr11:47082447-47082704	K562	blood:	n/a	n/a
12	BACH1	chr11:47082337-47082816	H1-hESC	embryonic stem cell:	n/a	n/a
13	BATF	chr11:47077876-47078195	GM12878	blood:	n/a	chr11:47078042-47078053
14	BATF	chr11:47042527-47042928	GM12878	blood:	n/a	n/a
15	BATF	chr11:47082351-47082726	GM12878	blood:	n/a	n/a
16	BATF	chr11:47082451-47082682	GM12878	blood:	n/a	n/a
17	BHLHE40	chr11:47077488-47078239	K562	blood:	n/a	n/a
18	BHLHE40	chr11:47109406-47109721	K562	blood:	n/a	n/a
19	BHLHE40	chr11:47089012-47089293	K562	blood:	n/a	n/a
20	CCNT2	chr11:47077775-47078232	K562	blood:	n/a	n/a
21	CEBPB	chr11:47083322-47083651	ECC-1	luminal epithelium:	n/a	n/a
22	CEBPB	chr11:47079015-47079195	A549	lung:	n/a	chr11:47079088-47079099
23	CEBPB	chr11:47083318-47083686	K562	blood:	n/a	n/a
24	CEBPB	chr11:47042503-47042505	IMR90	lung:	n/a	n/a
25	CEBPB	chr11:47063595-47063754	Hela-S3	cervix:	n/a	n/a
26	CEBPB	chr11:47063584-47063778	K562	blood:	n/a	n/a
27	CEBPB	chr11:47078941-47079236	HepG2	liver:	n/a	chr11:47079088-47079099
28	CEBPB	chr11:47083334-47083659	HepG2	liver:	n/a	n/a
29	CEBPB	chr11:47047976-47048082	HepG2	liver:	n/a	chr11:47048011-47048024 chr11:47048013-47048024 chr11:47048013-47048022
30	CEBPB	chr11:47050142-47050517	K562	blood:	n/a	chr11:47050243-47050254 chr11:47050243-47050254
31	CEBPB	chr11:47083296-47083696	H1-hESC	embryonic stem cell:	n/a	n/a
32	CEBPB	chr11:47084854-47085054	HepG2	liver:	n/a	chr11:47084948-47084959
33	CEBPB	chr11:47105484-47105849	IMR90	lung:	n/a	n/a
34	CEBPB	chr11:47047958-47048069	Hela-S3	cervix:	n/a	chr11:47048011-47048024 chr11:47048013-47048024 chr11:47048013-47048022
35	CEBPB	chr11:47083350-47083702	MCF-7	breast:	n/a	n/a
36	CEBPB	chr11:47095661-47095780	A549	lung:	n/a	n/a
37	CEBPB	chr11:47083369-47083671	IMR90	lung:	n/a	n/a
38	CEBPB	chr11:47083399-47083657	A549	lung:	n/a	n/a
39	CEBPB	chr11:47078944-47079215	IMR90	lung:	n/a	chr11:47079088-47079099
40	CEBPB	chr11:47095574-47095774	K562	blood:	n/a	n/a
41	CEBPB	chr11:47083355-47083668	Hela-S3	cervix:	n/a	n/a
42	CEBPB	chr11:47078910-47079282	K562	blood:	n/a	chr11:47079088-47079099
43	CEBPB	chr11:47077729-47078188	K562	blood:	n/a	n/a
44	CEBPB	chr11:47088333-47088516	IMR90	lung:	n/a	n/a
45	CEBPB	chr11:47097868-47097986	K562	blood:	n/a	n/a
46	CEBPB	chr11:47083279-47083744	MCF-7	breast:	n/a	n/a
47	CEBPB	chr11:47078909-47079288	H1-hESC	embryonic stem cell:	n/a	chr11:47079088-47079099
48	CEBPB	chr11:47084881-47085088	A549	lung:	n/a	chr11:47084948-47084959
49	CEBPB	chr11:47083233-47083754	A549	lung:	n/a	n/a
50	CEBPB	chr11:47078914-47079272	K562	blood:	n/a	chr11:47079088-47079099

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:47092992-47093042	HNPCEpiC	eye:	n/a
2	chr11:47083081-47083131	T-47D	breast:	n/a
3	chr11:47042656-47042706	T-47D	breast:	n/a
4	chr11:47077603-47077653	HEK293	kidney:	embryo
5	chr11:47083081-47083131	Caco-2	colon:	n/a
6	chr11:47077603-47077653	HCPEpiC	choroid plexus:	n/a
7	chr11:47092992-47093042	HRE	kidney:	n/a
8	chr11:47083081-47083131	MCF10A-Er-Src	breast:	n/a
9	chr11:47092992-47093042	SAEC	small airway:	n/a
10	chr11:47092992-47093042	Hela-S3	cervix:	n/a
11	chr11:47077603-47077653	AG04450	lung:	fetal
12	chr11:47077603-47077653	ECC-1	luminal epithelium:	n/a
13	chr11:47092992-47093042	HCF	heart:	n/a
14	chr11:47092992-47093042	HPAEpiC	pulmonary alveolar:	n/a
15	chr11:47042656-47042706	AG10803	skin:	n/a
16	chr11:47083081-47083131	AG04450	lung:	fetal
17	chr11:47083081-47083131	SKMC	muscle:	n/a
18	chr11:47092992-47093042	HMEC	breast:	n/a
19	chr11:47092992-47093042	SK-N-SH_RA	brain:	n/a
20	chr11:47077603-47077653	NHDF-neo	bronchial:	n/a
21	chr11:47042656-47042706	IMR90	lung:	fetal
22	chr11:47042656-47042706	HCM	heart:	n/a
23	chr11:47083081-47083131	GM12892	blood:	n/a
24	chr11:47077603-47077653	PFSK-1	brain:	n/a
25	chr11:47042656-47042706	BE2_C	brain:	n/a
26	chr11:47092992-47093042	HRCEpiC	kidney:	n/a
27	chr11:47042656-47042706	U87	brain:	n/a
28	chr11:47042656-47042706	HEEpiC	esophagus:	n/a
29	chr11:47092992-47093042	NHBE	bronchial:	n/a
30	chr11:47083081-47083131	GM19239	blood:	n/a
31	chr11:47092992-47093042	AoSMC	blood vessel:	n/a
32	chr11:47092992-47093042	HEEpiC	esophagus:	n/a
33	chr11:47077603-47077653	SK-N-MC	brain:	n/a
34	chr11:47092992-47093042	NT2-D1	testis:	n/a
35	chr11:47092992-47093042	BE2_C	brain:	n/a
36	chr11:47083081-47083131	HIPEpiC	eye:	n/a
37	chr11:47092992-47093042	U87	brain:	n/a
38	chr11:47083081-47083131	AG10803	skin:	n/a
39	chr11:47092992-47093042	H1-hESC	embryonic stem cell:	embryo
40	chr11:47083081-47083131	AoSMC	blood vessel:	n/a
41	chr11:47077603-47077653	GM12891	blood:	n/a
42	chr11:47077603-47077653	H1-hESC	embryonic stem cell:	embryo
43	chr11:47092992-47093042	LNCaP	prostate:	n/a
44	chr11:47083081-47083131	PrEC	prostate:	n/a
45	chr11:47077603-47077653	SAEC	small airway:	n/a
46	chr11:47077603-47077653	HRPEpiC	eye:	n/a
47	chr11:47042656-47042706	HAEpiC	amniotic membrane:	n/a
48	chr11:47042656-47042706	NT2-D1	testis:	n/a
49	chr11:47077603-47077653	CMK	blood:	n/a
50	chr11:47083081-47083131	SAEC	small airway:	n/a

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:47088319..47090594-chr11:47093365..47095673,2	MCF-7	breast:
2	chr11:47103099..47105198-chr11:47112800..47115813,3	K562	blood:
3	chr11:47041841..47045384-chr11:47049919..47053840,3	K562	blood:
4	chr11:47094186..47096896-chr11:47101702..47103857,2	MCF-7	breast:
5	chr11:47043884..47045816-chr11:47048717..47051419,2	K562	blood:
6	chr11:46941107..46942004-chr11:47044229..47044846,2	K562	blood:
7	chr11:47041841..47045384-chr11:47049919..47053840,3	K562	blood:
8	chr11:47043884..47045816-chr11:47048717..47051419,2	K562	blood:
9	chr11:47094186..47096896-chr11:47101702..47103857,2	MCF-7	breast:
10	chr11:47103099..47105198-chr11:47112800..47115813,3	K562	blood:
11	chr11:47085147..47087563-chr11:47092809..47094555,2	MCF-7	breast:
12	chr11:47048648..47051358-chr11:47053601..47056863,3	K562	blood:
13	chr11:47088319..47090594-chr11:47093365..47095673,2	MCF-7	breast:
14	chr11:47108705..47111315-chr11:47177201..47179314,2	K562	blood:
15	chr11:47072188..47073841-chr11:47075251..47077094,2	K562	blood:
16	chr11:47085147..47087563-chr11:47092809..47094555,2	MCF-7	breast:
17	chr11:47088601..47091574-chr11:47093803..47096124,2	K562	blood:
18	chr11:47088601..47091574-chr11:47093803..47096124,2	K562	blood:
19	chr11:47048648..47051358-chr11:47053601..47056863,3	K562	blood:

No data

Variant related genes	Relation type
C11orf49	TF binding region
ENSG00000271350	TF binding region
C11orf49	CpG island
ENSG00000271350	CpG island
ENSG00000149179	chromatin interactions

Extended variants
information (count: 2188 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:2188 , 50 per page) page: 1 2 3 4 5 6 7 ... 44

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs566281170	chr11:47041595-47041596	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs535311045	chr11:47041784-47041785	Enhancers Weak transcription Strong transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs551769094	chr11:47041845-47041846	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs55977742	chr11:47041877-47041878	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs181393567	chr11:47041891-47041892	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs71474200	chr11:47041936-47041937	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs557363994	chr11:47041947-47041948	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs574008802	chr11:47041956-47041957	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs548883929	chr11:47042044-47042045	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs148484395	chr11:47042054-47042055	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs536348601	chr11:47042119-47042120	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs184637636	chr11:47042155-47042156	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs142131406	chr11:47042157-47042158	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs376747392	chr11:47042158-47042159	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs189521773	chr11:47042229-47042230	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs180810393	chr11:47042420-47042421	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs564203698	chr11:47042430-47042431	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs140028738	chr11:47042452-47042453	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs543043022	chr11:47042454-47042455	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs563306621	chr11:47042457-47042458	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs145438432	chr11:47042468-47042469	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs542769608	chr11:47042500-47042501	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs559954806	chr11:47042514-47042515	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs181623926	chr11:47042533-47042534	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs528673227	chr11:47042620-47042621	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs551995708	chr11:47042656-47042657	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs185317843	chr11:47042676-47042677	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs543398333	chr11:47042685-47042686	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs531244022	chr11:47042807-47042808	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs147623742	chr11:47042818-47042819	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs567343337	chr11:47042879-47042880	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs567699971	chr11:47042885-47042886	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs536312040	chr11:47042997-47042998	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs374654637	chr11:47043009-47043010	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs186584065	chr11:47043016-47043017	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs566652539	chr11:47043132-47043133	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs534515075	chr11:47043233-47043234	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs190992782	chr11:47043293-47043294	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs577821336	chr11:47043302-47043303	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs543705728	chr11:47043328-47043329	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs181797211	chr11:47043369-47043370	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs186980834	chr11:47043446-47043447	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs142177829	chr11:47043455-47043456	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs78696237	chr11:47043456-47043457	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs191456109	chr11:47043484-47043485	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs12281425	chr11:47043536-47043537	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs12281521	chr11:47043555-47043556	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
48	rs181979092	chr11:47043585-47043586	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs566014397	chr11:47043587-47043588	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs74599584	chr11:47043588-47043589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Parathyroid adenoma	22454399	CNVD
Medulloblastoma	21979893	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Chordoma	18071362	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
small cell lung cancer	20016488	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Myelofibrosis	22110671	CNVD
Melanoma	18172304	CNVD
Intracranial ependymoma	16609018	CNVD
Myxofibrosarcoma	16751306	CNVD
Potocki-Shaffer syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	16608533	CNVD
Hirschsprung''s Disease	21712996	CNVD
Follicular lymphoma	20505157	CNVD
Colorectal cancer	21128281	CNVD
Breast cancer	20409316	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:773 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:47026600-47042200	Weak transcription	Small Intestine	intestine
2	chr11:47026800-47080200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
3	chr11:47027200-47042000	Weak transcription	Brain Hippocampus Middle	brain
4	chr11:47027400-47056000	Weak transcription	Fetal Intestine Small	intestine
5	chr11:47027800-47048000	Weak transcription	Primary hematopoietic stem cells	blood
6	chr11:47033000-47042000	Weak transcription	Fetal Lung	lung
7	chr11:47039600-47042000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
8	chr11:47040600-47043000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
9	chr11:47041000-47041800	Strong transcription	Hela-S3	cervix
10	chr11:47041000-47042400	Enhancers	Cortex derived primary cultured neurospheres	brain
11	chr11:47041000-47043600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
12	chr11:47041400-47043400	Enhancers	HUES64 Cell Line	embryonic stem cell
13	chr11:47041600-47042200	Enhancers	iPS-20b Cell Line	embryonic stem cell
14	chr11:47041600-47042400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
15	chr11:47041600-47043200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr11:47041600-47043400	Enhancers	GM12878-XiMat	blood
17	chr11:47041600-47043600	Enhancers	H1 Cell Line	embryonic stem cell
18	chr11:47041600-47043600	Enhancers	HUES48 Cell Line	embryonic stem cell
19	chr11:47041600-47043800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr11:47041800-47044800	Weak transcription	Hela-S3	cervix
21	chr11:47042000-47043000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
22	chr11:47042000-47043200	Enhancers	ES-I3 Cell Line	embryonic stem cell
23	chr11:47042000-47043200	Enhancers	Brain Hippocampus Middle	brain
24	chr11:47042000-47043200	Enhancers	Fetal Lung	lung
25	chr11:47042000-47043600	Enhancers	iPS-18 Cell Line	embryonic stem cell
26	chr11:47042000-47043800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
27	chr11:47042000-47043800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr11:47042200-47042800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
29	chr11:47042200-47043000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
30	chr11:47042200-47043600	Enhancers	Small Intestine	intestine
31	chr11:47042400-47043000	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
32	chr11:47042400-47043200	Enhancers	HUES6 Cell Line	embryonic stem cell
33	chr11:47042400-47043200	Enhancers	iPS-15b Cell Line	embryonic stem cell
34	chr11:47042400-47043200	Enhancers	Brain Substantia Nigra	brain
35	chr11:47042400-47043400	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
36	chr11:47042400-47043600	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
37	chr11:47042600-47043000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
38	chr11:47042600-47043200	Enhancers	Brain Cingulate Gyrus	brain
39	chr11:47042600-47043200	Enhancers	Brain Inferior Temporal Lobe	brain
40	chr11:47042600-47043200	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
41	chr11:47042600-47043200	Enhancers	Fetal Kidney	kidney
42	chr11:47042600-47043400	Enhancers	Brain Anterior Caudate	brain
43	chr11:47042600-47043600	Enhancers	Fetal Stomach	stomach
44	chr11:47042800-47043200	Enhancers	Brain Angular Gyrus	brain
45	chr11:47042800-47043600	Enhancers	iPS-20b Cell Line	embryonic stem cell
46	chr11:47042800-47043600	Enhancers	Brain Germinal Matrix	brain
47	chr11:47043000-47043400	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
48	chr11:47043000-47043800	Enhancers	Cortex derived primary cultured neurospheres	brain
49	chr11:47043000-47046000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
50	chr11:47043000-47050000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links